...SIX:NESN). Pronutria develops amino acid-based therapeutics to treat muscle, neurological and liver disorders. This year, Pronutria... ...orally ingested protein with an amino acid combination and physicochemical profile optimized for myopenia conditions. Pronutria... ...therapeutics, the company is developing medical foods and supplements. Nestle Health's Greg Behar will join Pronutria's...
...Big Data Innovation Lab (BDI-Lab) to identify rare diseases for therapies that are amenable to Pronutria’s... ...standard of care. The partners did not respond to inquiries. BioXcel Corp. , Branford, Conn. Pronutria...
...The companies partnered to use KineMed’s proteomics technology to evaluate the physiological effects of Pronutria’s biologics... ...restore cellular hemostasis. The companies did not disclose financial details. KineMed Inc. , Emeryville, Calif. Pronutria...
Pronutria Biosciences Inc. , Cambridge, Mass. Business: Endocrine/Metabolic, Neurology Date completed: 2015-05-28 Type: Venture financing Raised: $39 million Investors: Fidelity; Flagship Ventures; and other investors
WIR Staff...
...SIX:NESN). Pronutria develops amino acid-based therapeutics to treat muscle, neurological and liver disorders. This year, Pronutria... ...orally ingested protein with an amino acid combination and physicochemical profile optimized for myopenia conditions. Pronutria... ...therapeutics, the company is developing medical foods and supplements. Nestle Health's Greg Behar will join Pronutria's...
...Big Data Innovation Lab (BDI-Lab) to identify rare diseases for therapies that are amenable to Pronutria’s... ...standard of care. The partners did not respond to inquiries. BioXcel Corp. , Branford, Conn. Pronutria...
...The companies partnered to use KineMed’s proteomics technology to evaluate the physiological effects of Pronutria’s biologics... ...restore cellular hemostasis. The companies did not disclose financial details. KineMed Inc. , Emeryville, Calif. Pronutria...
Pronutria Biosciences Inc. , Cambridge, Mass. Business: Endocrine/Metabolic, Neurology Date completed: 2015-05-28 Type: Venture financing Raised: $39 million Investors: Fidelity; Flagship Ventures; and other investors
WIR Staff...